Three new drugs available to fight kidney cancer.

Suppr

超能文献

作者信息

Bankhead Charles

出版信息

J Natl Cancer Inst. 2006 Sep 6;98(17):1181-2. doi: 10.1093/jnci/djj384.

DOI:10.1093/jnci/djj384

PMID:16954469

Abstract

摘要

相似文献

Three new drugs available to fight kidney cancer.

J Natl Cancer Inst. 2006 Sep 6;98(17):1181-2. doi: 10.1093/jnci/djj384.

Trials probe new agents for kidney cancer.试验探索用于治疗肾癌的新药物。

JAMA. 2006 Jul 12;296(2):155-7. doi: 10.1001/jama.296.2.155.

Major treatment improvements encourage kidney cancer researchers to seek further gains.重大的治疗进展促使肾癌研究人员寻求更大的突破。

J Natl Cancer Inst. 2008 Sep 3;100(17):1202-3. doi: 10.1093/jnci/djn316. Epub 2008 Aug 26.

SU11248 and AG013736: current data and future trials in renal cell carcinoma.SU11248与AG013736：肾细胞癌的当前数据及未来试验

Clin Genitourin Cancer. 2005 Dec;4(3):175-80. doi: 10.3816/CGC.2005.n.029.

New hope for RCC patients.

Eur J Cancer. 2006 Aug;42(12):1693.

[Effect of angiogenesis inhibitors on renal cell carcinoma].[血管生成抑制剂对肾细胞癌的影响]

Magy Onkol. 2007;51(2):145-53. Epub 2007 Jul 29.

Temsirolimus for advanced renal-cell carcinoma.替西罗莫司用于晚期肾细胞癌。

N Engl J Med. 2007 Sep 6;357(10):1050; author reply 1050-1. doi: 10.1056/NEJMc071868.

Results of the first trial assessing adjuvant tyrosine kinase inhibitors in renal cell carcinoma do not reASSURE.评估肾细胞癌辅助性酪氨酸激酶抑制剂的首次试验结果并不令人安心。

Eur Urol. 2015 Sep;68(3):542-3. doi: 10.1016/j.eururo.2015.04.042. Epub 2015 May 20.

New treatment approaches in metastatic renal cell carcinoma.转移性肾细胞癌的新治疗方法

Curr Opin Urol. 2006 Sep;16(5):337-41. doi: 10.1097/01.mou.0000240305.78205.77.

New challenges in kidney cancer therapy: sunitinib.肾癌治疗的新挑战：舒尼替尼

Ann Oncol. 2007 Jul;18 Suppl 9:ix83-6. doi: 10.1093/annonc/mdm298.

引用本文的文献

The Underestimated Role of the p53 Pathway in Renal Cancer.p53通路在肾癌中被低估的作用

Cancers (Basel). 2022 Nov 22;14(23):5733. doi: 10.3390/cancers14235733.

RLIP76 Targeted Therapy for Kidney Cancer.肾癌的RLIP76靶向治疗。

Pharm Res. 2015 Oct;32(10):3123-36. doi: 10.1007/s11095-015-1723-1. Epub 2015 May 29.

Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.Rlip76 转运舒尼替尼和索拉非尼，并介导肾癌的耐药性。

Int J Cancer. 2010 Mar 15;126(6):1327-38. doi: 10.1002/ijc.24767.

RLIP76: a target for kidney cancer therapy.RLIP76：一种肾癌治疗靶点。

Cancer Res. 2009 May 15;69(10):4244-51. doi: 10.1158/0008-5472.CAN-08-3521. Epub 2009 May 5.

Key clinical issues in renal cancer: a challenge for proteomics.肾癌的关键临床问题：蛋白质组学面临的挑战

World J Urol. 2007 Dec;25(6):537-56. doi: 10.1007/s00345-007-0199-y. Epub 2007 Aug 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验